A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and colleagues around the ...

Kahles et al. then moved to validation using the CPTAC data by searching for potential peptides corresponding to neojunctions in breast and ovarian samples and determining whether these ...

CPTAC plans to add several hundred more assays over the next 2–3 years, and the portal will soon be open for contributions from the community. Of note, ...

University of Victoria Genome British Columbia Proteomics Centre has partnered with the U.S. National Cancer Institute (NCI) to make targeted proteomic assays accessible to the community through NCI’s ...

"Our study flips the script by showing that inherited DNA changes can influence how genes are expressed and how proteins-key drivers of cancer behavior-are produced and modified in tumors.

Proteomics analysis identifies potential drug targets for aggressive human cancers Date: March 4, 2021 Source: Baylor College of Medicine Summary: Researchers at Baylor College of Medicine show ...

Prognostic value of image subtypes was assessed via Cox regression on survival outcomes and validated with 189 samples from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) data set.